Targeted EGFR Antisense Gene Therapy for Brain Cancer
Department of Health and Human Services
Agency Tracking Number:
Solicitation Topic Code:
Small Business Information
ARMAGEN TECHNOLOGIES, INC.
ARMAGEN TECHNOLOGIES, INC., 914 COLORADO BLVD, SANTA MONICA, CA, 90401
Socially and Economically Disadvantaged:
AbstractDESCRIPTION (provided by applicant): The incidence of brain cancer in the U.S. is surprisingly high, and includes 15,000 new cases per year of the highly malignant primary brain cancer, glioblastoma multiforme (GBM), and about 150,000 cases per year of me
* information listed above is at the time of submission.